Role of CD73 and the purinergic signaling pathway in the pathogenesis of fusion-negative rhabdomyosarcoma

Purinergic Signal. 2024 Oct;20(5):469-471. doi: 10.1007/s11302-024-10013-2. Epub 2024 May 3.

Authors

Amelia Fascì¹, Silvia Deaglio²

Affiliations

¹ Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, via Nizza 52, Turin, 10126, Italy. [email protected].
² Laboratory of Functional Genomics, Department of Medical Sciences, University of Turin, via Nizza 52, Turin, 10126, Italy.

No abstract available

Keywords: Cell signaling; Fusion-negative rhabdomyosarcoma.

MeSH terms

5'-Nucleotidase* / metabolism
Animals
GPI-Linked Proteins / metabolism
Humans
Receptors, Purinergic / metabolism
Rhabdomyosarcoma* / metabolism
Rhabdomyosarcoma* / pathology
Signal Transduction* / physiology

Substances

5'-Nucleotidase
GPI-Linked Proteins
NT5E protein, human
Receptors, Purinergic

Grants and funding

23095/Associazione Italiana per la Ricerca sul Cancro